Principia Biopharma, A Sanofi Company

This study is testing whether an oral medication called rilzabrutinib can safely and effectively raise and maintain platelet counts in adults and adolescents with persistent or chronic immune thrombocytopenia (ITP). Participants were randomly assigned to take either the study dru…